Eintrag weiter verarbeiten
Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial: A Randomized Trial
Gespeichert in:
| Zeitschriftentitel: | Journal of Pediatric Gastroenterology and Nutrition |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | Journal of Pediatric Gastroenterology and Nutrition, 64, 2017, 3, S. 446-453 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Miklavcic, John J. Larsen, Bodil M.K. Mazurak, Vera C. Scalabrin, Deolinda M.F. MacDonald, Ian M. Shoemaker, Glen K. Casey, Linda Van Aerde, John E. Clandinin, Michael T. Miklavcic, John J. Larsen, Bodil M.K. Mazurak, Vera C. Scalabrin, Deolinda M.F. MacDonald, Ian M. Shoemaker, Glen K. Casey, Linda Van Aerde, John E. Clandinin, Michael T. |
|---|---|
| author |
Miklavcic, John J. Larsen, Bodil M.K. Mazurak, Vera C. Scalabrin, Deolinda M.F. MacDonald, Ian M. Shoemaker, Glen K. Casey, Linda Van Aerde, John E. Clandinin, Michael T. |
| spellingShingle |
Miklavcic, John J. Larsen, Bodil M.K. Mazurak, Vera C. Scalabrin, Deolinda M.F. MacDonald, Ian M. Shoemaker, Glen K. Casey, Linda Van Aerde, John E. Clandinin, Michael T. Journal of Pediatric Gastroenterology and Nutrition Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial Gastroenterology Pediatrics, Perinatology and Child Health |
| author_sort |
miklavcic, john j. |
| spelling |
Miklavcic, John J. Larsen, Bodil M.K. Mazurak, Vera C. Scalabrin, Deolinda M.F. MacDonald, Ian M. Shoemaker, Glen K. Casey, Linda Van Aerde, John E. Clandinin, Michael T. 0277-2116 1536-4801 Wiley Gastroenterology Pediatrics, Perinatology and Child Health http://dx.doi.org/10.1097/mpg.0000000000001283 <jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background:</jats:title><jats:p>Infants who are not breast‐fed benefit from formula with both docosahexaenoic acid (C22:6n3) and arachidonic acid (ARA; C20:4n6). The amount of ARA needed to support immune function is unknown. Infants who carry specific fatty acid desaturase (FADS) polymorphisms may require more dietary ARA to maintain adequate ARA status.</jats:p></jats:sec><jats:sec><jats:title>Objective:</jats:title><jats:p>The aim of the study was to determine whether ARA intake or FADS polymorphisms alter ARA levels of lymphocytes, plasma, and red blood cells in term infants fed infant formula.</jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p>Infants (N = 89) were enrolled in this prospective, double‐blind controlled study. Infants were randomized to consume formula containing 17 mg docosahexaenoic acid and 0, 25, or 34 mg ARA/100 kcal for 10 weeks. Fatty acid composition of plasma phosphatidylcholine and phosphatidylethanolamine, total fatty acids of lymphocytes and red blood cells, activation markers of lymphocytes, and polymorphisms in <jats:italic>FADS1</jats:italic> and <jats:italic>FADS2</jats:italic> were determined.</jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p>Lymphocyte ARA was higher in the 25‐ARA formula group than in the 0‐ or 34‐ARA groups. In plasma, 16:0/20:4 and 18:0/20:4 species of phosphatidylcholine and phosphatidylethanolamine were highest and 16:0/18:2 and 18:0/18:2 were lowest in the 34‐ARA formula group. In minor allele carriers of <jats:italic>FADS1</jats:italic> and <jats:italic>FADS2</jats:italic>, plasma ARA content was elevated only at the highest level of ARA consumed. B‐cell activation marker CD54 was elevated in infants who consumed formula containing no ARA.</jats:p></jats:sec><jats:sec><jats:title>Conclusions:</jats:title><jats:p>ARA level in plasma is reduced by low ARA consumption and by minor alleles in FADS. Dietary ARA may exert an immunoregulatory role on B‐cell activation by decreasing 16:0/18:2 and 18:0/18:2 species of phospholipids. ARA intake from 25 to 34 mg/100 kcal is sufficient to maintain cell ARA level in infants across genotypes.</jats:p></jats:sec> A Randomized Trial Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial Journal of Pediatric Gastroenterology and Nutrition |
| doi_str_mv |
10.1097/mpg.0000000000001283 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny9tcGcuMDAwMDAwMDAwMDAwMTI4Mw |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny9tcGcuMDAwMDAwMDAwMDAwMTI4Mw |
| institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
| imprint |
Wiley, 2017 |
| imprint_str_mv |
Wiley, 2017 |
| issn |
0277-2116 1536-4801 |
| issn_str_mv |
0277-2116 1536-4801 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
miklavcic2017reductionofarachidonateisassociatedwithincreaseinbcellactivationmarkerininfantsarandomizedtrialarandomizedtrial |
| publishDateSort |
2017 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Pediatric Gastroenterology and Nutrition |
| source_id |
49 |
| title_sub |
A Randomized Trial |
| title |
Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_unstemmed |
Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_full |
Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_fullStr |
Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_full_unstemmed |
Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_short |
Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_sort |
reduction of arachidonate is associated with increase in b‐cell activation marker in infants : a randomized trial |
| topic |
Gastroenterology Pediatrics, Perinatology and Child Health |
| url |
http://dx.doi.org/10.1097/mpg.0000000000001283 |
| publishDate |
2017 |
| physical |
446-453 |
| description |
<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background:</jats:title><jats:p>Infants who are not breast‐fed benefit from formula with both docosahexaenoic acid (C22:6n3) and arachidonic acid (ARA; C20:4n6). The amount of ARA needed to support immune function is unknown. Infants who carry specific fatty acid desaturase (FADS) polymorphisms may require more dietary ARA to maintain adequate ARA status.</jats:p></jats:sec><jats:sec><jats:title>Objective:</jats:title><jats:p>The aim of the study was to determine whether ARA intake or FADS polymorphisms alter ARA levels of lymphocytes, plasma, and red blood cells in term infants fed infant formula.</jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p>Infants (N = 89) were enrolled in this prospective, double‐blind controlled study. Infants were randomized to consume formula containing 17 mg docosahexaenoic acid and 0, 25, or 34 mg ARA/100 kcal for 10 weeks. Fatty acid composition of plasma phosphatidylcholine and phosphatidylethanolamine, total fatty acids of lymphocytes and red blood cells, activation markers of lymphocytes, and polymorphisms in <jats:italic>FADS1</jats:italic> and <jats:italic>FADS2</jats:italic> were determined.</jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p>Lymphocyte ARA was higher in the 25‐ARA formula group than in the 0‐ or 34‐ARA groups. In plasma, 16:0/20:4 and 18:0/20:4 species of phosphatidylcholine and phosphatidylethanolamine were highest and 16:0/18:2 and 18:0/18:2 were lowest in the 34‐ARA formula group. In minor allele carriers of <jats:italic>FADS1</jats:italic> and <jats:italic>FADS2</jats:italic>, plasma ARA content was elevated only at the highest level of ARA consumed. B‐cell activation marker CD54 was elevated in infants who consumed formula containing no ARA.</jats:p></jats:sec><jats:sec><jats:title>Conclusions:</jats:title><jats:p>ARA level in plasma is reduced by low ARA consumption and by minor alleles in FADS. Dietary ARA may exert an immunoregulatory role on B‐cell activation by decreasing 16:0/18:2 and 18:0/18:2 species of phospholipids. ARA intake from 25 to 34 mg/100 kcal is sufficient to maintain cell ARA level in infants across genotypes.</jats:p></jats:sec> |
| container_issue |
3 |
| container_start_page |
446 |
| container_title |
Journal of Pediatric Gastroenterology and Nutrition |
| container_volume |
64 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792344330221912067 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:05:24.184Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Reduction+of+Arachidonate+Is+Associated+With+Increase+in+B%E2%80%90Cell+Activation+Marker+in+Infants+%3A+A+Randomized+Trial&rft.date=2017-03-01&genre=article&issn=1536-4801&volume=64&issue=3&spage=446&epage=453&pages=446-453&jtitle=Journal+of+Pediatric+Gastroenterology+and+Nutrition&atitle=Reduction+of+Arachidonate+Is+Associated+With+Increase+in+B%E2%80%90Cell+Activation+Marker+in+Infants+%3A+A+Randomized+Trial&aulast=Clandinin&aufirst=Michael+T.&rft_id=info%3Adoi%2F10.1097%2Fmpg.0000000000001283&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792344330221912067 |
| author | Miklavcic, John J., Larsen, Bodil M.K., Mazurak, Vera C., Scalabrin, Deolinda M.F., MacDonald, Ian M., Shoemaker, Glen K., Casey, Linda, Van Aerde, John E., Clandinin, Michael T. |
| author_facet | Miklavcic, John J., Larsen, Bodil M.K., Mazurak, Vera C., Scalabrin, Deolinda M.F., MacDonald, Ian M., Shoemaker, Glen K., Casey, Linda, Van Aerde, John E., Clandinin, Michael T., Miklavcic, John J., Larsen, Bodil M.K., Mazurak, Vera C., Scalabrin, Deolinda M.F., MacDonald, Ian M., Shoemaker, Glen K., Casey, Linda, Van Aerde, John E., Clandinin, Michael T. |
| author_sort | miklavcic, john j. |
| container_issue | 3 |
| container_start_page | 446 |
| container_title | Journal of Pediatric Gastroenterology and Nutrition |
| container_volume | 64 |
| description | <jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background:</jats:title><jats:p>Infants who are not breast‐fed benefit from formula with both docosahexaenoic acid (C22:6n3) and arachidonic acid (ARA; C20:4n6). The amount of ARA needed to support immune function is unknown. Infants who carry specific fatty acid desaturase (FADS) polymorphisms may require more dietary ARA to maintain adequate ARA status.</jats:p></jats:sec><jats:sec><jats:title>Objective:</jats:title><jats:p>The aim of the study was to determine whether ARA intake or FADS polymorphisms alter ARA levels of lymphocytes, plasma, and red blood cells in term infants fed infant formula.</jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p>Infants (N = 89) were enrolled in this prospective, double‐blind controlled study. Infants were randomized to consume formula containing 17 mg docosahexaenoic acid and 0, 25, or 34 mg ARA/100 kcal for 10 weeks. Fatty acid composition of plasma phosphatidylcholine and phosphatidylethanolamine, total fatty acids of lymphocytes and red blood cells, activation markers of lymphocytes, and polymorphisms in <jats:italic>FADS1</jats:italic> and <jats:italic>FADS2</jats:italic> were determined.</jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p>Lymphocyte ARA was higher in the 25‐ARA formula group than in the 0‐ or 34‐ARA groups. In plasma, 16:0/20:4 and 18:0/20:4 species of phosphatidylcholine and phosphatidylethanolamine were highest and 16:0/18:2 and 18:0/18:2 were lowest in the 34‐ARA formula group. In minor allele carriers of <jats:italic>FADS1</jats:italic> and <jats:italic>FADS2</jats:italic>, plasma ARA content was elevated only at the highest level of ARA consumed. B‐cell activation marker CD54 was elevated in infants who consumed formula containing no ARA.</jats:p></jats:sec><jats:sec><jats:title>Conclusions:</jats:title><jats:p>ARA level in plasma is reduced by low ARA consumption and by minor alleles in FADS. Dietary ARA may exert an immunoregulatory role on B‐cell activation by decreasing 16:0/18:2 and 18:0/18:2 species of phospholipids. ARA intake from 25 to 34 mg/100 kcal is sufficient to maintain cell ARA level in infants across genotypes.</jats:p></jats:sec> |
| doi_str_mv | 10.1097/mpg.0000000000001283 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny9tcGcuMDAwMDAwMDAwMDAwMTI4Mw |
| imprint | Wiley, 2017 |
| imprint_str_mv | Wiley, 2017 |
| institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
| issn | 0277-2116, 1536-4801 |
| issn_str_mv | 0277-2116, 1536-4801 |
| language | English |
| last_indexed | 2024-03-01T17:05:24.184Z |
| match_str | miklavcic2017reductionofarachidonateisassociatedwithincreaseinbcellactivationmarkerininfantsarandomizedtrialarandomizedtrial |
| mega_collection | Wiley (CrossRef) |
| physical | 446-453 |
| publishDate | 2017 |
| publishDateSort | 2017 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Journal of Pediatric Gastroenterology and Nutrition |
| source_id | 49 |
| spelling | Miklavcic, John J. Larsen, Bodil M.K. Mazurak, Vera C. Scalabrin, Deolinda M.F. MacDonald, Ian M. Shoemaker, Glen K. Casey, Linda Van Aerde, John E. Clandinin, Michael T. 0277-2116 1536-4801 Wiley Gastroenterology Pediatrics, Perinatology and Child Health http://dx.doi.org/10.1097/mpg.0000000000001283 <jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background:</jats:title><jats:p>Infants who are not breast‐fed benefit from formula with both docosahexaenoic acid (C22:6n3) and arachidonic acid (ARA; C20:4n6). The amount of ARA needed to support immune function is unknown. Infants who carry specific fatty acid desaturase (FADS) polymorphisms may require more dietary ARA to maintain adequate ARA status.</jats:p></jats:sec><jats:sec><jats:title>Objective:</jats:title><jats:p>The aim of the study was to determine whether ARA intake or FADS polymorphisms alter ARA levels of lymphocytes, plasma, and red blood cells in term infants fed infant formula.</jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p>Infants (N = 89) were enrolled in this prospective, double‐blind controlled study. Infants were randomized to consume formula containing 17 mg docosahexaenoic acid and 0, 25, or 34 mg ARA/100 kcal for 10 weeks. Fatty acid composition of plasma phosphatidylcholine and phosphatidylethanolamine, total fatty acids of lymphocytes and red blood cells, activation markers of lymphocytes, and polymorphisms in <jats:italic>FADS1</jats:italic> and <jats:italic>FADS2</jats:italic> were determined.</jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p>Lymphocyte ARA was higher in the 25‐ARA formula group than in the 0‐ or 34‐ARA groups. In plasma, 16:0/20:4 and 18:0/20:4 species of phosphatidylcholine and phosphatidylethanolamine were highest and 16:0/18:2 and 18:0/18:2 were lowest in the 34‐ARA formula group. In minor allele carriers of <jats:italic>FADS1</jats:italic> and <jats:italic>FADS2</jats:italic>, plasma ARA content was elevated only at the highest level of ARA consumed. B‐cell activation marker CD54 was elevated in infants who consumed formula containing no ARA.</jats:p></jats:sec><jats:sec><jats:title>Conclusions:</jats:title><jats:p>ARA level in plasma is reduced by low ARA consumption and by minor alleles in FADS. Dietary ARA may exert an immunoregulatory role on B‐cell activation by decreasing 16:0/18:2 and 18:0/18:2 species of phospholipids. ARA intake from 25 to 34 mg/100 kcal is sufficient to maintain cell ARA level in infants across genotypes.</jats:p></jats:sec> A Randomized Trial Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial Journal of Pediatric Gastroenterology and Nutrition |
| spellingShingle | Miklavcic, John J., Larsen, Bodil M.K., Mazurak, Vera C., Scalabrin, Deolinda M.F., MacDonald, Ian M., Shoemaker, Glen K., Casey, Linda, Van Aerde, John E., Clandinin, Michael T., Journal of Pediatric Gastroenterology and Nutrition, Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial, Gastroenterology, Pediatrics, Perinatology and Child Health |
| title | Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_full | Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_fullStr | Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_full_unstemmed | Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_short | Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| title_sort | reduction of arachidonate is associated with increase in b‐cell activation marker in infants : a randomized trial |
| title_sub | A Randomized Trial |
| title_unstemmed | Reduction of Arachidonate Is Associated With Increase in B‐Cell Activation Marker in Infants : A Randomized Trial |
| topic | Gastroenterology, Pediatrics, Perinatology and Child Health |
| url | http://dx.doi.org/10.1097/mpg.0000000000001283 |